EXMGF 0.604   -0.041 -6.40% Updated: 04-18-2017 $EXMGF

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
114
EXMGF 0.604   -0.041 -6.40% Updated: 04-18-2017 $EXMGF
Last Trade: 4/18/2017 2:41:00 PM
Last 0.604   -0.041 -6.40%
Open 0.630
Previous Close 0.645
Day High / Low 0.630 / 0.604
Year High / Low 0.818 / 0.329
Volume 86,600
Projected Volume 86600 (177%)
# of Trades / Projected 7 / 7
Dividend / Yield - / -
Abnormal Activity ABNORMAL DAY DOWN
Abnormal Volume NO
Gap NONE
Candle BEARISH
Volatility Today LOW
Volatility Yesterday LOW
Price Relativity
From 40 Day High 92%
From 80 Day High 87%
From 150 Day High 87%
From 40 Day Low 102%
From 80 Day Low 140%
From 150 Day Low 229%
Pivot Analysis
Price Pivot $ 0.610
Day Resistance 1 $ 0.620
Day Support 1 $ 0.600
Day Resistance 2 $ 0.640
Day Support 2 $ 0.590
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 48,936
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 34,488
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bullish
Stochastics bearish
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend bearish
45 Day Trend bearish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY DOWN
Volatility Index Today LOW
Volatility Index Yesterday LOW
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

DeepCure Introduces Advanced STAT6 Inhibitor for Inflammation

Updated Category News Views 871

DeepCure's STAT6 Inhibitor Program DeepCure, an innovative therapeutics company harnessing the power of artificial intelligence to unveil groundbreaking therapies for inflammation and immune diseases, has made an exciting announcement. The company recently revealed the development of potent and selective oral small molecule inhibitors designed to target STAT6, a key...

Continue Reading
Microsoft Alumni Network Expands Board for Global Impact

Updated Category News Views 160

Microsoft Alumni Network Enhances Board Leadership The Microsoft Alumni Network, representing over 290,000 former employees from a tech giant, has announced a significant elevation in its board of trustees aimed at strengthening its governance and global outreach. These strategic appointments are not just about filling positions; they signify a dedicated effort to bolster...

Continue Reading
Carl Icahn's Noteworthy Investment in CVR Partners Stock

Updated Category News Views 122

Carl Icahn's Significant Investment in CVR Partners Recently, CARL ICAHN, a notable 10% owner of CVR Partners (UAN), made headlines with a remarkable insider buy. The latest SEC filing disclosed that ICAHN purchased 4,897 shares of CVR Partners, amounting to an investment of $367,016. The timing of this insider transaction, taking place just before a notable decline in...

Continue Reading
Capriotti's Expands with New Kapolei Location for Food Lovers

Updated Category News Views 140

Capriotti's Opens a New Location in Kapolei Award-winning sandwich chain Capriotti's Sandwich Shop is excited to announce the grand opening of its second location in Kapolei. Known for its delicious, hand-crafted cheesesteaks and signature subs, the opening marks a significant milestone for this beloved restaurant. Meet Soojung Heu: The Visionary Behind Capriotti's in...

Continue Reading
Stifel Financial Highlights Strong April 2025 Operating Results

Updated Category News Views 134

Stifel Financial Sees Growth in April 2025 ST. LOUIS, May 22, 2025 – Stifel Financial Corp. (NYSE: SF) recently released its operating results for April 2025, focusing on key performance metrics to inform investors. It's essential to note that while this data is promising, it does not directly correlate to earnings. Total Client Assets on the Rise Ronald J. Kruszewski,...

Continue Reading